ResearcherDongguk University Ilsan HospitalNo recent work listed
Jun Kyu Lee
Matched on ORCID iD 0000-0002-2694-3598; OpenAlex author ID A5041283626. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper
Papers 5
- Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment. Co-author DOI 10.1186/s12885-019-6193-0↗
- Multicenter phase II trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer. Co-author DOI 10.4251/wjgo.v10.i12.505↗
- A Case of Leukemoid Reaction in Pancreatic Ductal Adenocarcinoma. First author DOI 10.4166/kjg.2015.66.2.116↗
- Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e318249d62e↗
- Effects and mechanisms of the combination of suberoylanilide hydroxamic acid and bortezomib on the anticancer property of gemcitabine in pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e3182156d5a↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ji Kon Ryu · 3 shared papers, 2011–2019 · strength 0.15
- Paper Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment. DOI 10.1186/s12885-019-6193-0↗
- Paper Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. DOI 10.1097/mpa.0b013e318249d62e↗
- Paper Effects and mechanisms of the combination of suberoylanilide hydroxamic acid and bortezomib on the anticancer property … DOI 10.1097/mpa.0b013e3182156d5a↗
- Sang Hyub Lee · 3 shared papers, 2011–2018 · strength 0.14
- Paper Multicenter phase II trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer. DOI 10.4251/wjgo.v10.i12.505↗
- Paper Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. DOI 10.1097/mpa.0b013e318249d62e↗
- Paper Effects and mechanisms of the combination of suberoylanilide hydroxamic acid and bortezomib on the anticancer property … DOI 10.1097/mpa.0b013e3182156d5a↗
- Yong‐Tae Kim · 2 shared papers, 2012–2019 · strength 0.12
- Dong Kee Jang · 1 shared paper, 2019 · strength 0.09
- Woo Hyun Paik · 1 shared paper, 2019 · strength 0.09
- Min Su You · 1 shared paper, 2019 · strength 0.09
- Jin Ho Choi MD · 1 shared paper, 2019 · strength 0.09
- Jin‐Young Jang · 1 shared paper, 2019 · strength 0.09
- Sun‐Whe Kim · 1 shared paper, 2019 · strength 0.09
- Wooil Kwon · 1 shared paper, 2019 · strength 0.09
- Jong Jin Hyun · 1 shared paper, 2018 · strength 0.08
- Moon Jae Chung · 1 shared paper, 2018 · strength 0.08
- Huapyong Kang · 1 shared paper, 2018 · strength 0.08
- Ho Gak Kim · 1 shared paper, 2018 · strength 0.08
- Seungmin Bang · 1 shared paper, 2018 · strength 0.08
- Yong Bum Yoon · 2 shared papers, 2011–2012 · strength 0.06
- Paper Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. DOI 10.1097/mpa.0b013e318249d62e↗
- Paper Effects and mechanisms of the combination of suberoylanilide hydroxamic acid and bortezomib on the anticancer property … DOI 10.1097/mpa.0b013e3182156d5a↗
- Kyong Hee Hong · 1 shared paper, 2015 · strength 0.06
- In Woong Han · 1 shared paper, 2015 · strength 0.06
- Eo Jin Kim · 1 shared paper, 2015 · strength 0.06
- Jin‐Hyeok Hwang · 1 shared paper, 2012 · strength 0.03
- Dong‐Won Ahn · 1 shared paper, 2012 · strength 0.03
- Yong‐Tae Kim · 1 shared paper, 2011 · strength 0.03
- Won Jae Yoon · 1 shared paper, 2011 · strength 0.03
- Joo Kyung Park · 1 shared paper, 2011 · strength 0.03
- Sang Myung Woo · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.